Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Items 701–800 of 971
Kageyama, K., Yamagata, S., Akimoto, K., Sugiyama, A., Murasawa, S., & Suda, T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.023 · Cited by 13
Central actions of glucocorticoids in the control of body fluid homeostasis: Review
Ruginsk, S. G., da Silva, A. L., Ventura, R. R., Elias, L. L. K., & Antunes‐Rodrigues, J. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009000100010 · Cited by 13
“Furthermore, AVP and OT are weak secretagogues of adrenocorticotropic hormone (15-17), strongly suggesting an interaction between the HPA axis and the secretion of neurohypophyseal hormones.”
BackgroundThe physiology of corticotropin-releasing factor (CRF)
Raux-Demay, M. C., & Girard, F. (1985) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:19850709 · Cited by 12
Transgenic studies on the regulation of the anterior pituitary gland function by the hypothalamus
Wells, S. E., & Murphy, D. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/s0091-3022(02)00103-6 · Cited by 15
A novel vasopressin receptor in rat early proximal tubule
Jung, K. Y., & Endou, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81265-3 · Cited by 12
Bombesin Regulation of Adrenocorticotropin Release From Ovine Anterior Pituitary Cells
Au, C. L., Canny, B. J., Farnworth, P. G., & Giraud, A. S. (1997) · Peptides · doi:10.1016/s0196-9781(97)00049-1 · Cited by 12
Corticotropin-releasing factor and adrenal function in major depression
Nerozzi, D., Bersani, G., Melia, E., Magnani, A., Antonozzi, I., & Frajese, G. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350921 · Cited by 12
Leśniewska, B., Nowak, M., Miśkowiak, B., Nussdorfer, G. G., & Malendowicz, L. K. (1991) · Experimental Pathology · doi:10.1016/s0232-1513(11)80115-5 · Cited by 12
Dentate granule cells as a central cardioregulatory site in the rat
Privette, T. H., Wang, J. Q., Ingenito, A. J., & Terrian, D. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91473-7 · Cited by 12
Sandler, L. M., Burrin, J. M., Joplin, G. F., & Bloom, S. R. (1986) · BMJ · doi:10.1136/bmj.292.6519.511 · Cited by 12
Bohus, B., Koolhaas, J. M., Nyakas, C. J., Luiten, P. G. M., Versteeg, C. A. M., Korte, S. M., Jaarsma, D., Timmerman, W., & Eisenga, W. (1990) · Springer eBooks · doi:10.1007/978-94-009-1990-7_9 · Cited by 12
Yamagata, S., Talukder, A. H., Murasawa, S., Niioka, K., Kumagai, N., Takagi, M., Kawamura, M., Natsume, R., Abe, M., Uchida, K., et al. (2023) · Endocrinology · doi:10.1210/endocr/bqad109 · Cited by 12
Amygdala AVPR1A mediates susceptibility to chronic social isolation in female mice
François, M., Vranich, K. A., Delgado, I. C., Lafond, A., Lopatinsky, N. R., Davis, T., Lewis, E. M., Kuromaru, M., Hassouna, R., Williams, B. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64742-y · Cited by 11
Neurocircuit regulation of the hypothalamo–pituitary–adrenocortical stress response – an overview
Herman, J. P., Mueller, N. K., Figueiredo, H. F., & Cullinan, W. E. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80023-9 · Cited by 16
Castro, M. G., Estivariz, F. E., & Iturriza, F. C. (1988) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(88)90047-3 · Cited by 11
Castro, M. G. (1993) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(93)90016-w · Cited by 11
Pro-opiomelanocortin peptides in the human fetal pituitary
Ackland, J. F., Ratter, S. J., BOURNE, G. L., & REES, L. H. (1983) · Regulatory Peptides · doi:10.1016/0167-0115(83)90134-9 · Cited by 12
Current status of brain hypophysiotropic factors morphologic aspects
Merchenthaler, I. J. (1991) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(91)90028-l · Cited by 11
Neurochemical Coding of Adaptive Responses in the Limbic System
Herbert, J., & Schulkin, J. A. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50013-5 · Cited by 11
Kneprl, W., Vlaskovska, M. V., & Meyer, D. (1985) · Brain Research · doi:10.1016/0006-8993(85)91387-3 · Cited by 11
Nitrous oxide-induced c-Fos expression in the rat brain
Kaiyala, K. J., Thiele, T. E., Watson, C. H., & Ramsay, D. S. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04219-1 · Cited by 12
Modulation of Immunity and Neoplasia by Neuropeptides Released by Stressors
Yirmiya, R., Ben‐Eliyahu, S., Liebeskind, J. C., Shavit, Y., Gale, R. P., Taylor, A. N., & Weiner, H. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-482490-4.50017-1 · Cited by 11
Knepel, W., & Sch�fl, C. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00172685 · Cited by 11
“Vasopressin acts on the corticotrophs of the anterior pituitary gland so as to induce peptide hormone release as well as to potentiate hormone release induced by other ACTH-releasing factors, including CRF- 41 ( Gillies et al. 1982 ).”
BackgroundInfluentialDohanics, J., Linton, E. A., Lowry, P. J., & Makara, G. B. (1990) · Peptides · doi:10.1016/0196-9781(90)90109-i · Cited by 11
Self-citationTunstall, B. J., & Carmack, S. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1815-16.2016 · Cited by 11
“In contrast, vasopressin is a candidate facilitation mechanism, as vasopressin is known to be potently synergistic with CRF in causing release of adrenocorticotropic hormone (Gillies et al., 1982).”
BackgroundExercise and the Hypothalamic‐Pituitary‐Adrenal Axis
Inder, W. J., & Wittert, G. (2005) · Wiley eBooks · doi:10.1002/9780470757826.ch17 · Cited by 11
Westphal, M., Jaquet, P., & Wilson, C. B. (1986) · Acta Neuropathologica · doi:10.1007/bf00687976 · Cited by 11
Anatomical and ontogenetic studies of the human paraventriculo-infundibular corticoliberin system
Bresson, J.-L., Clavequin, M. C., FELLMANN, D., & Bugnon, C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90278-7 · Cited by 10
CNS regulation of reproduction: Peptidergic mechanisms
Renaud, L. P., Day, T. A., & Ferguson, A. V. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90187-4 · Cited by 10
Laguna-Abreu, M. T. C., Margatho, L. O., Germano, C. M. R., Antunes‐Rodrigues, J., Elias, L. L. K., & de Castro, M. (2007) · Stress · doi:10.1080/10253890701287614 · Cited by 10
“AVP and OT participate in the regulation of ACTH secretion, potentiating CRH action on the pituitary corticotrophs (Gillies et al. 1982; Rivier and Vale 1983).”
BackgroundTakao, T., Tojo, C., Nishioka, T., & Hashimoto, K. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02222-2 · Cited by 10
Koch, B., & Lutz‐Bucher, B. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90043-5 · Cited by 10
Pradier, P., & Dalle, M. (1996) · Reproduction Fertility and Development · doi:10.1071/rd9960111 · Cited by 10
Lamberts, S. W. J., Bons, E. G., & Zuiderwijk, J. M. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90442-x · Cited by 10
Millan, M. J., Millan, M. J., Członkowski, A., & Herz, A. (1984) · Brain Research · doi:10.1016/0006-8993(84)91424-0 · Cited by 11
Howlett, T. A., Grossman, A. B., McLoughlin, L., Perry, L., White, A. E., Coy, D. H., REES, L. H., & BESSER, G. M. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb03740.x · Cited by 10
Sawchenko, P. E. (1989) · Hans Selye symposia on neuroendocrinology and stress · doi:10.1007/978-1-4612-3514-9_7 · Cited by 12
Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis
Stojiljković, A. S., Čupić, Ž., Maćešić, S., Ivanović-Šašić, A., & Kolar-Anić, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.976323 · Cited by 9
Baba, K., Kawasaki, M., Nishimura, H., Suzuki, H., Matsuura, T., Ikeda, N., Fujitani, T., Yamanaka, Y., Tsukamoto, M., Ohnishi, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17477-5 · Cited by 10
Marir, R., Virsolvy, A., Wiśniewski, K., Mion, J., Haddou, D., Galibert, E., Meraïhi, Z., Desarménien, M. G., & Guillon, G. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12249 · Cited by 11
“AVP in synergism with corticotropinreleasing factor contributes to the regulation of adrenocorticotropic hormone release (Gillies et al., 1982; Abou-Samra et al., 1987), catecholamines (Grazzini et al.”
BackgroundLearning to cope with repeated stress
Leng, G., & Russell, J. A. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.331bk.x · Cited by 9
de Souza, L. M., & Franci, C. R. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.05.009 · Cited by 9
The Role of Vasopressin in Anxiety and Depression
Morales‐Medina, J. C., Witchey, S. K., & Caldwell, H. K. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_40 · Cited by 13
Smith, K. L., Roche, M., Jessop, D. S., & Finn, D. P. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.005 · Cited by 9
Stress, Alcohol Consumption, and the Hypothalamic-Pituitary-Adrenal Axis
Glavas, M. M., & Weinberg, J. (2006) · Humana Press eBooks · doi:10.1385/1-59259-952-4:165 · Cited by 9
Abnormal Hypothalamic-Pituitary-Adrenal Function in Anorexia Nervosa
(1987) · New England Journal of Medicine · doi:10.1056/nejm198701223160414 · Cited by 9
The cell blot assay in analysis of rat anterior pituitary cell secretion
Cimini, V., Noorden, S. V., Mahadeva, H., & Polak, J. M. (1994) · The Histochemical Journal · doi:10.1007/bf02388393 · Cited by 9
“In this technique, dissociated endocrine cells are cultured on a synthetic polyvinylidene difluoride (PVDF) membrane for a few hours, the duration depending on the experiment. The secreted substances become bound to the matrix of the membrane and can be immunostained. The membrane is translucent so that the resulting…”
MethodThe molecular pathology of pituitary hormone deficiency and resistance
Woods, K. A., Weber, A., & Clark, A. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80536-2 · Cited by 9
Holsboer, F., & Ising, M. (2024) · Pharmacopsychiatry · doi:10.1055/a-2372-3549 · Cited by 9
Management of Glucocorticoid Replacement in Adult Growth Hormone Deficiency
Nyström, H. F., & Johannsson, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097573 · Cited by 8
“the serum cortisol concentration is increased through enhanced production and secretion from the adrenal glands via the influence of its major regulator, ACTH. Corticotropin-releasing hormone and arginine vasopressin synergistically stimulate ACTH secretion by corticotroph cells [”
BackgroundAkieda‐Asai, S., Ohta, R., Shirota, M., Jaroenporn, S., Watanabe, G., & Taya, K. (2011) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.60.509 · Cited by 9
“duces ACTH release from the pituitary gland, which results in the adrenocortical release of corticosterone [21, 35].”
BackgroundOdermatt, J., Bolliger, R., Hersberger, L., Ottiger, M., Christ‐Crain, M., Briel, M., Bucher, H. C., Müeller, B., & Schüetz, P. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0151 · Cited by 8
Otubo, A., Kawakami, N., Maejima, S., Ueda, Y., Morris, J. F., Sakamoto, T., & Sakamoto, H. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12875 · Cited by 8
“In many studies, AVP has been reported to potentiate the ACTH secretory activity of CRF at the ME level (7-9).”
BackgroundSocial effects on AVT and CRF systems
Bäckström, T., Thörnqvist, P., & Winberg, S. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-00995-w · Cited by 8
What can we Learn from Sampling Hypophysial Portal Blood?
Clarke, I. J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514283.ch7 · Cited by 8
Heightened Cortisol Response to Administration of Naloxone in Tourette's Syndrome
Sandyk, R., & Bamford, C. R. (1988) · International Journal of Neuroscience · doi:10.3109/00207458808985707 · Cited by 8
Pivonello, R., Faggiano, A., Filippella, M., Somma, C. D., Martino, M. C. D., Gaccione, M., Lombardi, G., & Colao, A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344064 · Cited by 8
Watanuki, Y., Takayasu, S., Kageyama, K., Iwasaki, Y., Sakihara, S., Terui, K., Nigawara, T., & Suda, T. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.022 · Cited by 8
Liu, J., Robinson, P. J., Funder, J. W., & Engler, D. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90232-1 · Cited by 9
Hyponatremia and Adrenocortical Function in Patients with Severe Bacterial Infections
Faber, M. T., Flachs, H., Frimodt‐Møller, N., & Lindholm, J. (1993) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549309169677 · Cited by 8
Vasopressin uptake by hypothalamopituitary axis and pineal gland in guinea pigs
Zloković, B. V., Hyman, S., McComb, J. G., Tang, G., Rezai, A. R., & Weiss, M. H. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.4.e633 · Cited by 8
Role of vasopressin in stimulation of ACTH secretion by angiotensin II in conscious dogs
Klingbeil, C., KEIL, L. C., Chang, D., & Reid, I. A. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.1.e52 · Cited by 8
Biró, É., Gardi, J., Vecsernyés, M., Julesz, J., Tóth, G. K., & Telegdy, G. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00460-2 · Cited by 8
Cover, P. O., Laycock, J. F., GARTSIDE, I. B., & Buckingham, J. C. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00296.x · Cited by 9
Tracer, H. L., & Loh, Y. P. (1993) · Neuropeptides · doi:10.1016/0143-4179(93)90098-u · Cited by 8
Schafer, M. K.-H., Herman, J. P., & Watson, S. J. (1989) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-10726-1_2 · Cited by 8
Sliwowska, J. H., Zhang, X., & Weinberg, J. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195183139.003.0010 · Cited by 12
Mezey, É., Young, W. S., Siegel, R. E., & Kovács, K. (1987) · Progress in brain research · doi:10.1016/s0079-6123(08)60201-0 · Cited by 8
Gold, P. W., Kling, M. A., Demitrack, M. A., Whitfield, H. J., Kalogeras, K. T., Loriaux, D. L., & Chrousos, G. P. (1988) · Current topics in neuroendocrinology · doi:10.1007/978-3-642-72738-2_2 · Cited by 8
Engler, D. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90202-j · Cited by 9
Fukuda, N., Honda, M., & Hatano, M. (1987) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.51.556 · Cited by 7
Stress, Opioid Peptides, and Their Receptors
Przewłocki, R. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50014-7 · Cited by 10
Gajewska, A., Zwierzchowski, L., & Kochman, K. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01202.x · Cited by 7
Körperliche Belastung, endogene Opiate und Schmerz
Droste, C. (1991) · Der Schmerz · doi:10.1007/bf02528099 · Cited by 8
Westphal, M., Jaquet, P., & Wilson, C. B. (1986) · Acta Neuropathologica · doi:10.1007/bf00687971 · Cited by 8
“The results obtained in our culture system confirm existing evidence of the concerted action of CRF and AVP ( Gillies et al. 1982 ).”
ResultJard, S., & Baulieu, É.-É. (1990) · Springer eBooks · doi:10.1007/978-94-011-3060-8_6 · Cited by 7
Lloyd, J. M., Tibolt, R. E., & Childs, G. V. (1991) · Current topics in pathology · doi:10.1007/978-3-642-75515-6_6 · Cited by 7
Measuring the activity of brain adrenergic receptors in man
Al‐Damluji, S. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346801 · Cited by 7
Schulte, H., Allolio, B., FROHWEIN, U. S., Benker, G., & REINWEIN, D. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03603.x · Cited by 7
Wong, L., & Murphy, D. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00355-6 · Cited by 10
Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat
Buckingham, J. C. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90592-2 · Cited by 7
The pulsatility of ACTH secretion in the rat anterior pituitary cell perifusion system
Deng, Q., Zhang, Z., & Wu, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000455984 · Cited by 6
Liu, Z., Liu, Z., Xu, X., Zhou, Y., Hu, C., Zhou, H., Li, Z., Guo, F., Zhou, Z., Wang, Y., et al. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.09.009 · Cited by 6
Kallaras, C., Angelopoulos, N., Bountzioukas, S., Mavroudis, K., Karamouzis, M., & Guiba-Tziampiri, O. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03346279 · Cited by 6
Sugimoto, K., Ohmomo, H., Shutoh, F., Nogami, H., & Hisano, S. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.11.010 · Cited by 7
Heida, J. E., Minović, I., van Faassen, M. H. J. R., Kema, I. P., Boertien, W. E., Bakker, S. J. L., van Beek, A. P., & Gansevoort, R. T. (2020) · American Journal of Nephrology · doi:10.1159/000511000 · Cited by 6
Mink, D., Lang, R. E., �stermann, E., & Bock, R. (1986) · Cell and Tissue Research · doi:10.1007/bf00215904 · Cited by 6
“(3) Vasopressin participates in the regulation of ACTH (Yates et al. 1971 ; Aizawa et al. 1982; Giguere and Labrie 1982; Gillies et al. 1982; Turkelson et al. 1982; Rivier and Vale 1983a, b; DeBold et al. 1984), and in a state of sodium deficiency, ACTH can stimulate the secretion of aldosterone (Laragh and Scaly 1973…”
BackgroundCirculating Corticotropin-Releasing Factor in Pregnancy
Linton, E. A., Wolfe, C. D. A., Behan, D. P., & Lowry, P. J. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5799-5_9 · Cited by 7
Self-citationArginine Vasopressin V1-Receptor Antagonism in an Ovine Model of Acute Myocardial Infarction
Charles, C. J., Donald, R. A., Ikram, H., Prickett, T. C. R., & Richards, M. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199811000-00014 · Cited by 6
Hypothalamohypophysiotropic Peptide Systems
Sagar, S. M., & Martin, J. B. (1986) · Comprehensive physiology · doi:10.1002/cphy.cp010408 · Cited by 6
Dual Control of Corticotropin Secretion: Isolation of Corticotropin-Inhibiting Factor
Redei, E. E., & Evans, C. J. (1989) · Hans Selye symposia on neuroendocrinology and stress · doi:10.1007/978-1-4612-3514-9_6 · Cited by 6
Pralong, F. P., Linton, E. A., Favrod-Coune, C. A., Lowry, P. J., Muller, A. F., & Gaillard, R. C. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00420.x · Cited by 6
Self-citationDifferential effects of dptyr(me)avp, a vasopressin antagonist, upon foot shock analgesia
Kordower, J. H., & Bodnar, R. J. (1985) · International Journal of Neuroscience · doi:10.3109/00207458508985394 · Cited by 7
Shutt, D. A., Connell, R., & Fell, L. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90258-0 · Cited by 6
Weld, M. M., & Fryer, J. N. (1988) · General and Comparative Endocrinology · doi:10.1016/0016-6480(88)90023-8 · Cited by 6
Signals from the hypothalamus to the pituitary during chronic immune responses
Harbuz, M. S., & Lightman, S. L. (1997) · Springer eBooks · doi:10.1007/978-1-4471-0931-0_2 · Cited by 6
Abraham, R. R., CAMPBELL, E. A., Gillham, B., Thody, A. J., ALTAHER, A. R. H., PRYSOR‐JONES, A., Wynn, V., Jones, M. T., & JENKINS, J. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03597.x · Cited by 6
Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.
Hashimoto, K., Suemaru, S., Takao, T., Sugawara, M., Hattori, T., Kageyama, J., Takahashi, K., & Ota, Z. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113561 · Cited by 6
Barna, I., Ács, Z., & Koenig, J. I. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90065-b · Cited by 6
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery
Calò, G., Rizzi, A., Traina, L., & Regoli, D. C. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00635-2 · Cited by 6
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.